These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19885619)

  • 21. Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma.
    Shimazu Y; Kurozumi K; Ichikawa T; Fujii K; Onishi M; Ishida J; Oka T; Watanabe M; Nasu Y; Kumon H; Date I
    Gene Ther; 2015 Feb; 22(2):146-54. PubMed ID: 25394252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical safety and efficacy of in situ REIC/Dkk-3 gene therapy for prostate cancer.
    Kawauchi K; Watanabe M; Kaku H; Huang P; Sasaki K; Sakaguchi M; Ochiai K; Huh NH; Nasu Y; Kumon H
    Acta Med Okayama; 2012; 66(1):7-16. PubMed ID: 22358134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canine REIC/Dkk-3 interacts with SGTA and restores androgen receptor signalling in androgen-independent prostate cancer cell lines.
    Kato Y; Ochiai K; Kawakami S; Nakao N; Azakami D; Bonkobara M; Michishita M; Morimatsu M; Watanabe M; Omi T
    BMC Vet Res; 2017 Jun; 13(1):170. PubMed ID: 28599655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor suppressor REIC/Dkk-3 interacts with the dynein light chain, Tctex-1.
    Ochiai K; Watanabe M; Ueki H; Huang P; Fujii Y; Nasu Y; Noguchi H; Hirata T; Sakaguchi M; Huh NH; Kashiwakura Y; Kaku H; Kumon H
    Biochem Biophys Res Commun; 2011 Aug; 412(2):391-5. PubMed ID: 21835165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression pattern of REIC/Dkk-3 in mouse squamous epithelia.
    Kataoka K; Du G; Maehara N; Murata H; Sakaguchi M; Huh N
    Clin Exp Dermatol; 2012 Jun; 37(4):428-31. PubMed ID: 22329665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of REIC/Dkk-3 in normal and hyperproliferative epidermis.
    Du G; Kataoka K; Sakaguchi M; Abarzua F; Than SS; Sonegawa H; Makino T; Shimizu T; Huh NH
    Exp Dermatol; 2011 Mar; 20(3):273-7. PubMed ID: 21323747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector.
    Watanabe M; Sakaguchi M; Kinoshita R; Kaku H; Ariyoshi Y; Ueki H; Tanimoto R; Ebara S; Ochiai K; Futami J; Li SA; Huang P; Nasu Y; Huh NH; Kumon H
    Oncol Rep; 2014 Mar; 31(3):1089-95. PubMed ID: 24398705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation status of REIC/Dkk-3 gene in human malignancies.
    Hayashi T; Asano H; Toyooka S; Tsukuda K; Soh J; Shien T; Taira N; Maki Y; Tanaka N; Doihara H; Nasu Y; Huh NH; Miyoshi S
    J Cancer Res Clin Oncol; 2012 May; 138(5):799-809. PubMed ID: 22274868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer.
    Hirata T; Watanabe M; Kaku H; Kobayashi Y; Yamada H; Sakaguchi M; Takei K; Huh NH; Nasu Y; Kumon H
    Int J Oncol; 2012 Aug; 41(2):559-64. PubMed ID: 22665039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor apoptosis in prostate cancer by PGD(2) and its metabolite 15d-PGJ(2) in murine model.
    Nakamura M; Tsumura H; Satoh T; Matsumoto K; Maruyama H; Majima M; Kitasato H
    Biomed Pharmacother; 2013 Feb; 67(1):66-71. PubMed ID: 23206752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanistic analysis of resistance to REIC/Dkk-3-induced apoptosis in human bladder cancer cells.
    Kobayashi T; Sakaguchi M; Tanimoto R; Abarzua F; Takaishi M; Kaku H; Kataoka K; Saika T; Nasu Y; Miyazaki M; Kumon H; Huh NH
    Acta Med Okayama; 2008 Dec; 62(6):393-401. PubMed ID: 19122685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraperitoneal administration of an adenovirus vector carrying REIC/Dkk-3 suppresses peritoneal dissemination of scirrhous gastric carcinoma.
    Than SS; Kataoka K; Sakaguchi M; Murata H; Abarzua F; Taketa C; Du G; Yashiro M; Yanagihara K; Nasu Y; Kumon H; Huh NH
    Oncol Rep; 2011 Apr; 25(4):989-95. PubMed ID: 21249317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promising Gene Therapy Using an Adenovirus Vector Carrying REIC/Dkk-3 Gene for the Treatment of Biliary Cancer.
    Tanaka E; Uchida D; Shiraha H; Kato H; Ohyama A; Iwamuro M; Watanabe M; Kumon H; Okada H
    Curr Gene Ther; 2020; 20(1):64-70. PubMed ID: 32148193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Internalization of REIC/Dkk-3 protein by induced pluripotent stem cell-derived embryoid bodies and extra-embryonic tissues.
    Kataoka K; Sakaguchi M; Li KP; Taketa C; Yamamoto K; Du G; Funahashi H; Murata H; Huh NH
    Int J Mol Med; 2010 Dec; 26(6):853-9. PubMed ID: 21042779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dickkopf-3/REIC functions as a suppressor gene of tumor growth.
    Hsieh SY; Hsieh PS; Chiu CT; Chen WY
    Oncogene; 2004 Dec; 23(57):9183-9. PubMed ID: 15516983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heat shock proteins play a crucial role in tumor-specific apoptosis by REIC/Dkk-3.
    Abarzua F; Sakaguchi M; Tanimoto R; Sonegawa H; Li DW; Edamura K; Kobayashi T; Watanabe M; Kashiwakura Y; Kaku H; Saika T; Nakamura K; Nasu Y; Kumon H; Huh NH
    Int J Mol Med; 2007 Jul; 20(1):37-43. PubMed ID: 17549386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression pattern and functional role of REIC/Dkk-3 in the development of cutaneous squamous cell carcinoma.
    Shin JM; Choi DK; Kang HY; Sohn KC; Lee Y; Kim CD; Lee JH; Park BC
    J Dermatol Sci; 2016 Oct; 84(1):88-96. PubMed ID: 27354306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The induction of antigen-specific CTL by in situ Ad-REIC gene therapy.
    Ariyoshi Y; Watanabe M; Eikawa S; Yamazaki C; Sadahira T; Hirata T; Araki M; Ebara S; Nasu Y; Udono H; Kumon H
    Gene Ther; 2016 May; 23(5):408-14. PubMed ID: 26836118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer.
    Tanimoto R; Abarzua F; Sakaguchi M; Takaishi M; Nasu Y; Kumon H; Huh NH
    Int J Mol Med; 2007 Mar; 19(3):363-8. PubMed ID: 17273781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases.
    Thudi NK; Martin CK; Murahari S; Shu ST; Lanigan LG; Werbeck JL; Keller ET; McCauley LK; Pinzone JJ; Rosol TJ
    Prostate; 2011 May; 71(6):615-25. PubMed ID: 20957670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.